Zharkova, M.S.; Komlev, A.S.; Filatenkova, T.A.; Sukhareva, M.S.; Vladimirova, E.V.; Trulioff, A.S.; Orlov, D.S.; Dmitriev, A.V.; Afinogenova, A.G.; Spiridonova, A.A.;
et al. Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons. Pharmaceutics 2023, 15, 291.
https://doi.org/10.3390/pharmaceutics15010291
AMA Style
Zharkova MS, Komlev AS, Filatenkova TA, Sukhareva MS, Vladimirova EV, Trulioff AS, Orlov DS, Dmitriev AV, Afinogenova AG, Spiridonova AA,
et al. Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons. Pharmaceutics. 2023; 15(1):291.
https://doi.org/10.3390/pharmaceutics15010291
Chicago/Turabian Style
Zharkova, Maria S., Aleksey S. Komlev, Tatiana A. Filatenkova, Maria S. Sukhareva, Elizaveta V. Vladimirova, Andrey S. Trulioff, Dmitriy S. Orlov, Alexander V. Dmitriev, Anna G. Afinogenova, Anna A. Spiridonova,
and et al. 2023. "Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons" Pharmaceutics 15, no. 1: 291.
https://doi.org/10.3390/pharmaceutics15010291
APA Style
Zharkova, M. S., Komlev, A. S., Filatenkova, T. A., Sukhareva, M. S., Vladimirova, E. V., Trulioff, A. S., Orlov, D. S., Dmitriev, A. V., Afinogenova, A. G., Spiridonova, A. A., & Shamova, O. V.
(2023). Combined Use of Antimicrobial Peptides with Antiseptics against Multidrug-Resistant Bacteria: Pros and Cons. Pharmaceutics, 15(1), 291.
https://doi.org/10.3390/pharmaceutics15010291
